Evercore ISI analyst Umer Raffat initiated coverage of Metsera (MTSR) with an Outperform rating. Metsera has a full portfolio of GLP-1 ...
BofA initiated coverage of Metsera (MTSR) with a Buy rating and $38 price target implying over 20% share upside. Metsera is a clinical-stage ...
Metformin is an old drug. In its earliest form, it was an extract from lilacs and was purportedly used in the 1700s to treat ...
Eli Lilly said it has launched new doses of its obesity treatment drug and reduced its prices.
New research finds older women achieve the best results with weight loss injections – thanks to consistent tracking and ...
Weight loss medications like Wegovy and Zepbound are gaining popularity as millions turn to them for quick results and ...